Aurobindo Pharma
AUROPHARMA.NS
#2147
Rank
โ‚น617.10 B
Marketcap
โ‚น1,062
Share price
0.40%
Change (1 day)
-2.62%
Change (1 year)

Revenue for Aurobindo Pharma (AUROPHARMA.NS)

Revenue in 2024 (TTM): โ‚น304.88 Billion

According to Aurobindo Pharma 's latest financial reports the company's current revenue (TTM ) is โ‚น316.30 Billion. an increase over the revenue in the year 2023 that were of โ‚น275.91 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Aurobindo Pharma from 2012 to 2024

Annual revenue

Year Revenue Change
2024 โ‚น304.88 B10.5%
2023 โ‚น275.91 B14.8%
2022 โ‚น240.33 B2%
2021 โ‚น235.62 B-4.33%
2020 โ‚น246.29 B13.87%
2019 โ‚น216.29 B18.67%
2018 โ‚น182.26 B13.26%
2017 โ‚น160.92 B5.91%
2016 โ‚น151.94 B14.64%
2015 โ‚น132.54 B18.06%
2014 โ‚น112.27 B54.48%
2013 โ‚น72.67 B34.54%
2012 โ‚น54.01 B